The molecular mechanisms of transient leukemia by GATA1 mutation and development of molecular target therapy
Project/Area Number |
20390289
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | Hirosaki University |
Principal Investigator |
ITO Etsuro Hirosaki University, 大学院・医学研究科, 教授 (20168339)
|
Co-Investigator(Kenkyū-buntansha) |
TSUTOMU Toki 弘前大学, 大学院・医学研究科, 講師 (50195731)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥18,590,000 (Direct Cost: ¥14,300,000、Indirect Cost: ¥4,290,000)
Fiscal Year 2010: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2009: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2008: ¥7,930,000 (Direct Cost: ¥6,100,000、Indirect Cost: ¥1,830,000)
|
Keywords | GATA1 / 一過性白血病 / TAM / ダウン症候群 / 分子標的療法 / 白血病 / 転写因子 / 発現クローニング / GATA1s / 発現量 / ダウン症 / JAK3 / KIT |
Research Abstract |
We performed this study to understand the role of GATA1 mutations in the development of transient leukemia and develop the molecular target therapy, and found the following results. 1. We found the essential role of SCF/KIT signaling in the proliferation of transient leukemia in Down syndrome. 2. We showed that the mutations in the GATA1 genes affect the expression levels of GATA1s protein. Furthermore, GATA1s low mutations were significantly associated with a risk of progression to ML-DS and lower WBC counts.
|
Report
(4 results)
Research Products
(40 results)
-
[Journal Article] Relapse of aplastic anemia in children after immunosuppressive therapy : a report from the Japan Childhood Aplastic Anemia Study Group.2011
Author(s)
Kamio T, Ito E, Ohara A, Kosaka Y, Tsuchida M, Yagasaki H, Mugishima H, Yabe H, Morimoto A, Ohga S, Muramatsu H, Hama A, Kaneko T, Nagasawa M, Kikuta A, Osugi Y, Bessho F, Nakahata T, Tsukimoto I, Kojima S
-
Journal Title
Haematologica. 96(6)
Pages: 814-819
Related Report
-
-
-
-
-
[Journal Article] Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia.2010
Author(s)
Kanezaki R, Toki T, Terui K, Xu G, Wang RN, Shimada A, Hama A, Kanegane H, Kawakami K, Endo M, Hasegawa D, Kogawa K, Adachi S, Ikeda Y, Iwamoto S, Taga T, Kosaka Y, Kojima S, Hayashi Y, Ito E.
-
Journal Title
Blood 116(22)
Pages: 4631-8
Related Report
-
-
[Journal Article] Array-based genomic resequencing of human leukemia.2010
Author(s)
Yamashita Y, Yuan J, Suetake I, Suzuki H, Ishikawa Y, Choi YL, Ueno T, Soda M, Hamada T, Haruta H, Takada S, Miyazaki Y, Kiyoi H, Ito E, Naoe T, Tomonaga M, Toyota M, Tajima S, Iwama A, Mano H
-
Journal Title
Oncogene 29(25)
Pages: 3723-31
Related Report
-
[Journal Article] PU.1-mediated upregulation of M-CSFR is critical for MOZ-leukemia stem cell potential.2010
Author(s)
Aikawa Y, Katsumoto T, Zhang P, Shima H, Shino M, Terui K, Ito E, Ohno H, Stanley ER, Singh H, Tenen DG, Kitabayashi I
-
Journal Title
Nature Medicine 16(5)
Pages: 580-585
Related Report
-
[Journal Article] Mutations in the ribosomal protein genes in Japanese patients with Diamond-Blackfan anemia.2010
Author(s)
Konno Y, Toki T, Tandai S, Xu G, Wang RN, Terui K, Ohga S, Hara T, Hama A, Kojima S, Hasegawa D, Kosaka Y, Yanagisawa R, Koike K, Kanai R, Imai T, Hongo T, Park MJ, Sugita K, Ito E
-
Journal Title
Haematologica 95(8)
Pages: 1293-9
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome.2008
Author(s)
Sato T, Toki T, Kanezaki R, Xu G, Terui K, Kanegane H, Miura M, Adachi S, Migita M, Morinaga S, Nakano T, Endo M, Kojima S, Kiyoi H, Mano H, Ito E
-
Journal Title
Brit J Haematol. 141
Pages: 681-688
Related Report
-
-
-
-
-
-
-
-
-
-
-